Breaking News, Promotions & Moves

AstraZeneca Names New CEO

Roche vet to take over AZ

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Pascal Soriot has been named chief executive officer of AstraZeneca. Dr. Soriot will take on his new responsibilities and join the AstraZeneca PLC board as an executive director on October 1, 2012. Simon Lowth will remain as AZ’s interim chief executive officer until Dr. Soriot joins the company; after that, he will resume his responsibilities as chief financial Officer and will continue to serve as an executive director on the board. Dr. Soriot joins AstraZeneca from Roche AG, where he h...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters